SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-060053
Filing Date
2012-02-14
Accepted
2012-02-14 14:26:02
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d295918d10q.htm 10-Q 331183
2 SECTION 302 CEO CERTIFICATION d295918dex311.htm EX-31.1 10341
3 SECTION 302 CFO CERTIFICATION d295918dex312.htm EX-31.2 10359
4 SECTION 906 CEO CERTIFICATION d295918dex321.htm EX-32.1 5010
5 SECTION 906 CFO CERTIFICATION d295918dex322.htm EX-32.2 4906
  Complete submission text file 0001193125-12-060053.txt   1571637

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lfvn-20111231.xml EX-101.INS 125687
7 XBRL TAXONOMY EXTENSION SCHEMA lfvn-20111231.xsd EX-101.SCH 9944
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lfvn-20111231_cal.xml EX-101.CAL 34776
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lfvn-20111231_def.xml EX-101.DEF 11715
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lfvn-20111231_lab.xml EX-101.LAB 128260
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lfvn-20111231_pre.xml EX-101.PRE 79422
Mailing Address 10813 S. RIVER FRONT PARKWAY STE. 500 SOUTH JORDAN UT 84095
Business Address 10813 S. RIVER FRONT PARKWAY STE. 500 SOUTH JORDAN UT 84095 858-312-8000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-30489 | Film No.: 12607810
SIC: 2834 Pharmaceutical Preparations